![]() ![]() Natus reminds you that future results may differ materially from those forward-looking statements due to a number of risk factors. Forward-looking statements are those focused on future performance, results, plans and events, and include the company’s expected results for 2015. Some of the information to be furnished in today’s session will constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Then, Jonathan Kennedy, Senior Vice President and Chief Financial Officer of Natus will summarize the company’s financial results, and then Jim Hawkins will conclude the prepared remarks with comments about the company’s financial guidance for 2015 before opening the call up to questions. The agenda for today’s call will be as follows: Jim Hawkins, President and Chief Executive Officer of Natus will present opening comments. If you have not received the news release or if you would like to be added to the company’s distribution list, please email your request to This call is being broadcast live over the Internet on the company’s website at and a replay of the call will be available on the website for the next 90 days. As a reminder, this conference call is being recorded today, July 22, 2015, and contains time-sensitive information that is accurate only as of today.Įarlier today, Natus Medical released financial results for the second quarter 2015. Later, we will conduct a question-and-answer session. At this time, all participants are in listen-only mode. Welcome to the Natus Medical Second Quarter 2015 Financial Results Conference Call. Ladies and gentlemen, thank you for standing by. ![]() Larry Haimovitch - Haimovitch Medical Technology Consultants Jonathan Kennedy - SVP of Finance and CFOīrian Weinstein - William Blair & Company ( BABY) Q2 2015 Earnings Conference Call J11:00 AM ET To read this article on click here.Natus Medical, Inc. NATUS MEDICAL (BABY): Free Stock Analysis ReportĮXACTECH INC (EXAC): Free Stock Analysis Report Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Is BABY going up? Or down? Predict to see what others think: Up or Down EXAC, which carries a Zacks Rank #1 (Strong Buy). Investors interested in the medical instruments industry may consider better-ranked stock like Exactech Inc. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.īABY currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. The medical instruments company has seen a flat record when it comes to current year estimate revisions over the past few weeks (0 increases, 0 decreases), and the consensus for earnings hasn’t been in a trend either. ![]() On Jan 11, 2016, the company announced its outlook for the first quarter and full year 2016, apart from lowering its revenue outlook for the fourth quarter of 2015. This continues the recent downtrend for BABY, as the stock is now down nearly 23% in the past one-month time frame. The move came on pretty good volume too with far more shares changing hands than in a normal session. BABY saw a big move last session, as the company’s shares fell by almost 12% on the day. ![]()
0 Comments
Leave a Reply. |